Zimmer Biomet
817 hedge funds and large institutions have $21B invested in Zimmer Biomet in 2017 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 278 increasing their positions, 293 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.91% less ownership
Funds ownership: 88.86% → 87.96% (-0.91%)
5% less repeat investments, than reductions
Existing positions increased: 278 | Existing positions reduced: 293
25% less call options, than puts
Call options by funds: $40.3M | Put options by funds: $54M
Holders
817
Holding in Top 10
21
Calls
$40.3M
Puts
$54M
Top Buyers
| 1 | +$1.99B | |
| 2 | +$121M | |
| 3 | +$99M | |
| 4 |
GCM
Glenview Capital Management
New York
|
+$94.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$89.7M |
Top Sellers
| 1 | -$162M | |
| 2 | -$90.3M | |
| 3 | -$83.7M | |
| 4 |
HM
HealthCor Management
New York
|
-$69.6M |
| 5 |
Millennium Management
New York
|
-$67.9M |